These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 22051352)

  • 21. Trend of stroke incidence in a Japanese population: Takashima stroke registry, 1990-2001.
    Kita Y; Turin TC; Ichikawa M; Sugihara H; Morita Y; Tomioka N; Rumana N; Okayama A; Nakamura Y; Abbott RD; Ueshima H
    Int J Stroke; 2009 Aug; 4(4):241-9. PubMed ID: 19689749
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thrombolysis at 3-4.5 hours after acute ischemic stroke onset--evidence from the Canadian Alteplase for Stroke Effectiveness Study (CASES) registry.
    Shobha N; Buchan AM; Hill MD;
    Cerebrovasc Dis; 2011; 31(3):223-8. PubMed ID: 21178345
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current status of intravenous thrombolysis for acute ischemic stroke in Asia.
    Sharma VK; Ng KW; Venketasubramanian N; Saqqur M; Teoh HL; Kaul S; Srivastava PM; Sergentanis T; Suwanwela N; Nguyen TH; Lawrence Wong KS; Chan BP
    Int J Stroke; 2011 Dec; 6(6):523-30. PubMed ID: 22111797
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prioritizing interventions to improve rates of thrombolysis for ischemic stroke.
    California Acute Stroke Pilot Registry (CASPR) Investigators
    Neurology; 2005 Feb; 64(4):654-9. PubMed ID: 15728287
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early neurological deterioration within 24 hours after intravenous rt-PA therapy for stroke patients: the Stroke Acute Management with Urgent Risk Factor Assessment and Improvement rt-PA Registry.
    Mori M; Naganuma M; Okada Y; Hasegawa Y; Shiokawa Y; Nakagawara J; Furui E; Kimura K; Yamagami H; Kario K; Okuda S; Koga M; Minematsu K; Toyoda K
    Cerebrovasc Dis; 2012; 34(2):140-6. PubMed ID: 22854333
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stroke Incidence and Outcomes in Northeastern Greece: The Evros Stroke Registry.
    Tsivgoulis G; Patousi A; Pikilidou M; Birbilis T; Katsanos AH; Mantatzis M; Asimis A; Papanas N; Skendros P; Terzoudi A; Karamanli A; Kouroumichakis I; Zebekakis P; Maltezos E; Piperidou C; Vadikolias K; Heliopoulos I
    Stroke; 2018 Feb; 49(2):288-295. PubMed ID: 29335330
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of telemedicine implementation in thrombolytic use for acute ischemic stroke: the University of Pittsburgh Medical Center telestroke network experience.
    Amorim E; Shih MM; Koehler SA; Massaro LL; Zaidi SF; Jumaa MA; Reddy VK; Hammer MD; Jovin TG; Wechsler LR
    J Stroke Cerebrovasc Dis; 2013 May; 22(4):527-31. PubMed ID: 23489955
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravenous thrombolysis for acute cerebral ischaemia: comparison of outcomes between patients treated at working versus nonworking hours.
    Bodenant M; Leys D; Debette S; Cordonnier C; Dumont F; Hénon H; Girot M; Lucas C; Devos D; Defebvre L; Deplanque D; Leclerc X; Bordet R
    Cerebrovasc Dis; 2010; 30(2):148-56. PubMed ID: 20551630
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Epidemiology of stroke in the elderly].
    Pozsegovits K; Kazuo S; Nagy Z
    Ideggyogy Sz; 2006 Nov; 59(11-12):449-53. PubMed ID: 17203883
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Results of intravenous thrombolysis within 4.5 to 6 hours and updated results within 3 to 4.5 hours of onset of acute ischemic stroke recorded in the Safe Implementation of Treatment in Stroke International Stroke Thrombolysis Register (SITS-ISTR): an observational study.
    Ahmed N; Kellert L; Lees KR; Mikulik R; Tatlisumak T; Toni D;
    JAMA Neurol; 2013 Jul; 70(7):837-44. PubMed ID: 23689267
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Barriers to the use of intravenous tissue plasminogen activator for in-hospital strokes.
    Bunch ME; Nunziato EC; Labovitz DL
    J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):808-11. PubMed ID: 21640608
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renal impairment reduces the efficacy of thrombolytic therapy in acute ischemic stroke.
    Power A; Epstein D; Cohen D; Bathula R; Devine J; Kar A; Taube D; Duncan N; Ames D
    Cerebrovasc Dis; 2013; 35(1):45-52. PubMed ID: 23428996
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety, effectiveness, and practicality of endovascular therapy within the first 3 hours of acute ischemic stroke onset.
    Mathews MS; Sharma J; Snyder KV; Natarajan SK; Siddiqui AH; Hopkins LN; Levy EI
    Neurosurgery; 2009 Nov; 65(5):860-5; discussion 865. PubMed ID: 19834397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proportions of stroke subtypes among men and women > or =40 years of age in an urban Japanese city in 1992, 1997, and 2002.
    Kitamura A; Nakagawa Y; Sato M; Iso H; Sato S; Imano H; Kiyama M; Okada T; Okada H; Iida M; Shimamoto T
    Stroke; 2006 Jun; 37(6):1374-8. PubMed ID: 16690900
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characteristics and outcome of patients with early complete neurological recovery after thrombolysis for acute ischemic stroke.
    Blinzler C; Breuer L; Huttner HB; Schellinger PD; Schwab S; Köhrmann M
    Cerebrovasc Dis; 2011; 31(2):185-90. PubMed ID: 21160181
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravenous thrombolysis with rt-PA in acute ischemic stroke patients aged older than 80 years in Italy.
    Toni D; Lorenzano S; Agnelli G; Guidetti D; Orlandi G; Semplicini A; Toso V; Caso V; Malferrari G; Fanucchi S; Bartolomei L; Prencipe M
    Cerebrovasc Dis; 2008; 25(1-2):129-35. PubMed ID: 18073466
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TESPI (Thrombolysis in Elderly Stroke Patients in Italy): a randomized controlled trial of alteplase (rt-PA) versus standard treatment in acute ischaemic stroke in patients aged more than 80 years where thrombolysis is initiated within three hours after stroke onset.
    Lorenzano S; Toni D;
    Int J Stroke; 2012 Apr; 7(3):250-7. PubMed ID: 22292526
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and outcomes following thrombolytic treatment in stroke patients who had received prior treatment with anticoagulants.
    Matute MC; Masjuan J; Egido JA; Fuentes B; Simal P; Díaz-Otero F; Reig G; Díez-Tejedor E; Gil-Nuñez A; Vivancos J; Alonso de Leciñana M
    Cerebrovasc Dis; 2012; 33(3):231-9. PubMed ID: 22261670
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stroke Incidence and Survival in Ludwigshafen am Rhein, Germany: the Ludwigshafen Stroke Study (LuSSt).
    Palm F; Urbanek C; Rose S; Buggle F; Bode B; Hennerici MG; Schmieder K; Inselmann G; Reiter R; Fleischer R; Piplack KO; Safer A; Becher H; Grau AJ
    Stroke; 2010 Sep; 41(9):1865-70. PubMed ID: 20689086
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prediction of thrombolytic therapy after stroke-bypass transportation: the Maria Prehospital Stroke Scale score.
    Hasegawa Y; Sasaki N; Yamada K; Ono H; Kumai J; Tsumura K; Suzuki K; Nozaki H; Nakayama H; Takumi I; Nikaido H; Katabami T; Ueda T; Suzuki S; Iwai R; Takahashi H; Shigeno T
    J Stroke Cerebrovasc Dis; 2013 May; 22(4):514-9. PubMed ID: 23489953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.